These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23636138)

  • 1. Mitochondria, prostate cancer, and biopsy sampling error.
    Parr RL; Mills J; Harbottle A; Creed JM; Crewdson G; Reguly B; Guimont FS
    Discov Med; 2013 Apr; 15(83):213-20. PubMed ID: 23636138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens.
    Maki J; Robinson K; Reguly B; Alexander J; Wittock R; Aguirre A; Diamandis EP; Escott N; Skehan A; Prowse O; Thayer RE; Froberg MK; Wilson MJ; Maragh S; Jakupciak JP; Wagner PD; Srivastava S; Dakubo GD; Parr RL
    Am J Clin Pathol; 2008 Jan; 129(1):57-66. PubMed ID: 18089489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.
    Freedland SJ; deGregorio F; Sacoolidge JC; Elshimali YI; Csathy GS; Dorey F; Reiter RE; Aronson WJ
    J Urol; 2003 Apr; 169(4):1325-30. PubMed ID: 12629353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Scattoni V; Raber M; Capitanio U; Abdollah F; Roscigno M; Angiolilli D; Maccagnano C; Gallina A; Saccà A; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2011 Oct; 60(4):834-41. PubMed ID: 21820797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy.
    Amamoto R; Yagi M; Song Y; Oda Y; Tsuneyoshi M; Naito S; Yokomizo A; Kuroiwa K; Tokunaga S; Kato S; Hiura H; Samori T; Kang D; Uchiumi T
    Cancer Sci; 2011 Mar; 102(3):639-47. PubMed ID: 21205079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
    J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical problems of systematic prostate needle biopsy in the detection of prostate cancer].
    Suzuki H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):16-20. PubMed ID: 12557699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized prediction of tumor response and cancer progression on prostate needle biopsy.
    Donovan MJ; Khan FM; Fernandez G; Mesa-Tejada R; Sapir M; Zubek VB; Powell D; Fogarasi S; Vengrenyuk Y; Teverovskiy M; Segal MR; Karnes RJ; Gaffey TA; Busch C; Haggman M; Hlavcak P; Freedland SJ; Vollmer RT; Albertsen P; Costa J; Cordon-Cardo C
    J Urol; 2009 Jul; 182(1):125-32. PubMed ID: 19450827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy.
    Antunes AA; Srougi M; Dall'Oglio MF; Crippa A; Campagnari JC; Leite KR
    BJU Int; 2005 Dec; 96(9):1258-63. PubMed ID: 16287441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer].
    Morote Robles J; López Pacios M; Encabo Duró G; de Torres Ramírez I
    Actas Urol Esp; 1999; 23(7):583-6. PubMed ID: 10488612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
    Mayes JM; Mouraviev V; Sun L; Tsivian M; Madden JF; Polascik TJ
    Urol Oncol; 2011; 29(2):166-70. PubMed ID: 19451000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas.
    Bolenz C; Gierth M; Grobholz R; Köpke T; Semjonow A; Weiss C; Alken P; Michel MS; Trojan L
    BJU Int; 2009 May; 103(9):1184-9. PubMed ID: 19154463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
    J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.